Clinical Trial Update: Dynamic CtDNA-guided Targeted Therapy in DLBCL [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating dynamic ctDNA-guided targeted therapy in diffuse large B-cell lymphoma is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: Ruijin Hospital | Conditions: Diffuse Large B Cell Lymphoma (DLBCL) | Phase 2 | Status: NOT_YET_RECRUITING